Merck & Co. Inc. Stock
Merck & Co. Inc. Stock
A loss of -1.630% shows a downward development for Merck & Co. Inc..
We see a rather positive sentiment for Merck & Co. Inc. with 11 Buy predictions and 2 Sell predictions.
As a result the target price of €80.00 shows a positive potential of 32.450% compared to the current price of €60.40 for Merck & Co. Inc..
Criterium "Revenue growth" is seen as the biggest plus for Merck & Co. Inc. stock. Negative votes have not been in the majority for any criteria for this stock
We see a rather positive sentiment for Merck & Co. Inc. with 11 Buy predictions and 2 Sell predictions.
As a result the target price of €80.00 shows a positive potential of 32.450% compared to the current price of €60.40 for Merck & Co. Inc..
Criterium "Revenue growth" is seen as the biggest plus for Merck & Co. Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Merck & Co. Inc. in the next few years
Pros
1
Revenue growth >5% per year expected
1
EBIT growth >5% per year expected
1
Could be worthwhile Investment >10% per year
Cons
0
-
Performance of Merck & Co. Inc. vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Merck & Co. Inc. | -1.630% | -1.603% | -8.358% | -16.802% | -7.530% | 38.257% | 34.003% |
| Abbott Laboratories | -0.160% | -3.569% | 5.799% | 34.057% | 13.189% | 108.292% | 181.293% |
| BioMarin Pharmaceutical Inc. | -5.330% | -2.279% | -8.121% | -19.522% | -3.966% | 0.703% | -2.491% |
| AbbVie Inc. | 1.270% | 0.559% | -2.873% | 7.585% | 3.097% | -7.941% | 75.632% |
Comments
Sell Merck & Co. Inc.
Buy Merck & Co. Inc.
Other discussions about Merck & Co. Inc. Stock
Trading Merck & Co. Inc.
Trading Merck & Co. Inc.
